MedTrace Logo

Dynamic Splinting for Excessive Pronation Following CVA

NCT00900692 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-07-11

No results posted yet for this study

Summary

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

Conditions

  • Pronation Contracture

Interventions

DEVICE

Dynasplint

Dynamic splinting utilizes the protocols of Low-Load Prolonged Stretch (LLPS) with calibrated adjustable tension to increase Total End Range Time (TERT)to reduce contracture. The Dynasplint or "Experimental" group will add this therapy to their standard of care regimen

Sponsors & Collaborators

  • Dynasplint Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Marc E Duerden, MD · Rehabilitation Associates of Indiana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2016-09-30
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900692 on ClinicalTrials.gov